Skip to content

Medical-device intelligence

PCC: Stimulator, Nerve, Electrical, Transcutaneous, For Migraine

FDA product code PCC: Stimulator, Nerve, Electrical, Transcutaneous, For Migraine. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
PCC
FDA device name
Stimulator, Nerve, Electrical, Transcutaneous, For Migraine
Device class
2
Regulation number
882.5891
Medical specialty
Neurology
Review panel
NE

FDA definition

Used to apply an electrical current to a patient's cranium through electrodes placed on the skin.
Explore neurology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

17 clearance records and 0 recall records in the covered releases, across 9 source company names and 1 product codes. Dated history runs from Mar 4, 2016 to Apr 16, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202610
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
PCC · Stimulator, Nerve, Electrical, Transcutaneous, For Migraine170

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

17 matching records
Device / recordCompany in FDA recordSourceSource date
Enso for MigraineK254216 · PCCHinge Health, Inc.510(k)Apr 16, 2026FDA decision date
ELEXIR 2.0 (ALLIVE3)K242719 · PCCNu Eyne Co., Ltd.510(k)Nov 6, 2024FDA decision date
CEFALY Connected - OTC, CEFALY Connected - RxK234029 · PCCCefaly Technology510(k)Jul 18, 2024FDA decision date
DOOPANGK232749 · PCCYbrain, Inc.510(k)Jun 11, 2024FDA decision date
Milieve (YPS-301BD)K233751 · PCCSoterix Medical, Inc.510(k)Jun 3, 2024FDA decision date
TENS device-HeadaTerm 2 (Model: YF-HT2)K230782 · PCCWat Medical Technology, Inc.510(k)Feb 26, 2024FDA decision date
Cefaly Dual Enhanced with RFID - OTC, Cefaly Dual Enhanced with RFID - Rx, Cefaly Dual Connected - OTC, Cefaly Dual Connected - RxK212071 · PCCCefaly Technology510(k)Dec 13, 2022FDA decision date
RelivionK212106 · PCCNeurolief , Ltd.510(k)Aug 2, 2021FDA decision date
ElexirK211380 · PCCNu Eyne Co., Ltd.510(k)Jul 30, 2021FDA decision date
Migraine Tens Digital Pain RelieverK210364 · PCCShenzhen Dongdixin Technology Co., Ltd.510(k)Jun 17, 2021FDA decision date
RelivionK203419 · PCCNeurolief , Ltd.510(k)Feb 16, 2021FDA decision date
Cefaly DualK201895 · PCCCefaly Technology510(k)Sep 29, 2020FDA decision date
ALLIVEK192773 · PCCNu Eyne Co., Ltd.510(k)Dec 6, 2019FDA decision date
TENS device-HeadaTerm, eEspressK172450 · PCCWat Medical Technology (Ningbo) Co., Ltd.510(k)Sep 13, 2018FDA decision date
Cefaly DualK173006 · PCCCefaly Technology510(k)Nov 28, 2017FDA decision date
Cefaly AcuteK171446 · PCCCefaly Technology510(k)Sep 15, 2017FDA decision date
CefalyK160237 · PCCCefaly Technology510(k)Mar 4, 2016FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗